Home/Filings/4/0001209191-18-047212
4//SEC Filing

Koh Bong Y 4

Accession 0001209191-18-047212

CIK 0001600132other

Filed

Aug 15, 8:00 PM ET

Accepted

Aug 16, 7:31 PM ET

Size

23.1 KB

Accession

0001209191-18-047212

Insider Transaction Report

Form 4
Period: 2018-08-14
Transactions
  • Purchase

    Common Stock

    2018-08-14$0.65/sh+190,977$123,8686,202,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-15$0.65/sh+272,000$175,9026,474,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-16$0.65/sh+66,393$43,1096,541,163 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2018-08-16$0.65/sh+66,393$43,1096,541,163 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-15$0.65/sh+272,000$175,9026,474,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-14$0.65/sh+190,977$123,8686,202,770 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2018-08-16$0.65/sh+66,393$43,1096,541,163 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-14$0.65/sh+190,977$123,8686,202,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-15$0.65/sh+272,000$175,9026,474,770 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2018-08-15$0.65/sh+272,000$175,9026,474,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-16$0.65/sh+66,393$43,1096,541,163 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-14$0.65/sh+190,977$123,8686,202,770 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2018-08-14$0.65/sh+190,977$123,8686,202,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-15$0.65/sh+272,000$175,9026,474,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-16$0.65/sh+66,393$43,1096,541,163 total(indirect: By funds)
Koh Bong Y
10% Owner
Transactions
  • Purchase

    Common Stock

    2018-08-14$0.65/sh+190,977$123,8686,202,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-16$0.65/sh+66,393$43,1096,541,163 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-15$0.65/sh+272,000$175,9026,474,770 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2018-08-16$0.65/sh+66,393$43,1096,541,163 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-14$0.65/sh+190,977$123,8686,202,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-15$0.65/sh+272,000$175,9026,474,770 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2018-08-14$0.65/sh+190,977$123,8686,202,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-15$0.65/sh+272,000$175,9026,474,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-16$0.65/sh+66,393$43,1096,541,163 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2018-08-16$0.65/sh+66,393$43,1096,541,163 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-14$0.65/sh+190,977$123,8686,202,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-15$0.65/sh+272,000$175,9026,474,770 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2018-08-16$0.65/sh+66,393$43,1096,541,163 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-15$0.65/sh+272,000$175,9026,474,770 total(indirect: By funds)
  • Purchase

    Common Stock

    2018-08-14$0.65/sh+190,977$123,8686,202,770 total(indirect: By funds)
Footnotes (4)
  • [F1]This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co-Investment Holdings II, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons.
  • [F2]Consists of (i) 173,617 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 17,360 shares purchased by VHCP Co-Investment Holdings III, LLC.
  • [F3]Consists of (i) 247,275 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 24,725 shares purchased by VHCP Co-Investment Holdings III, LLC.
  • [F4]Consists of (i) 60,358 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 6,035 shares purchased by VHCP Co-Investment Holdings II, LLC.

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1
  • filerCIK 0001615979

Filing Metadata

Form type
4
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 7:31 PM ET
Size
23.1 KB